News and Trends 3 Oct 2022
Oncopeptides starts European commercialization of myeloma drug in Germany
Swedish biotech company Oncopeptides AB has initiated the commercial launch of Pepaxti (melphalan flufenamide) in Germany. It marks the first market in Europe where the drug is being launched. On…
